Literature review and expert opinion on the treatment of high-risk acute myeloid leukemia in patients who are eligible for intensive chemotherapy
In patients with Acute Myeloid Leukemia (AML), the assessment of disease risk plays a central role in the era of personalized medicine.Indeed, integrating baseline clinical and biological features on a Rolling Trays case-by-case basis is not only essential to select which treatment would likely result in a higher probability of achieving complete r